Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paul Barton Duell"'
Autor:
Paul Barton Duell, Bruce A. Warden
Publikováno v:
Therapeutic Apheresis and Dialysis. 26:12-17
Patients with homozygous familial hypercholesterolemia (FH) have severe hypercholesterolemia from birth and if untreated may experience very early onset of coronary artery disease in childhood or young adulthood with an aggressive course resulting in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8acd1a3d526dd9e0251a0d7f004f1bec
https://doi.org/10.1111/1744-9987.13856
https://doi.org/10.1111/1744-9987.13856
Autor:
Paul Barton Duell, Bruce A. Warden
Publikováno v:
Journal of cardiovascular pharmacology. 78(2)
Hypercholesterolemia is a leading cause of cardiovascular morbidity and mortality. Accordingly, efforts to lower apolipoprotein B-containing lipoproteins in plasma are the centerpiece of strategies for cardiovascular prevention and treatment in prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f10670f2506d1b045a1549f6b88505
https://pubmed.ncbi.nlm.nih.gov/33990512
https://pubmed.ncbi.nlm.nih.gov/33990512
Autor:
Warren D. Kruger, Robert A. Gluckman, Peter H. Anderson, Peter C. Block, David L. Hess, Manuel R. Malinow, Beverley E. Phillipson, Barbara M. Upson, Paul Barton Duell
Publikováno v:
New England Journal of Medicine. 338:1009-1015
The Food and Drug Administration (FDA) has recommended that cereal-grain products be fortified with folic acid to prevent congenital neural-tube defects. Since folic acid supplementation reduces levels of plasma homocyst(e)ine, or plasma total homocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742aeaea75c3fcfedffdfb88835cecce
https://doi.org/10.1056/nejm199804093381501
https://doi.org/10.1056/nejm199804093381501
Autor:
M.R. Malinow, C.R. Holzgang, F.J. Nieto, Peter H. Anderson, Warren D. Kruger, Peter C. Block, B. Upson, Deborah L. Seltzer, R.A. Gluckman, Q.R. Lin, Paul Barton Duell, D.L. Hess
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 17:1157-1162
Abstract Elevated concentration of plasma total homocysteine (tHcy) is a common risk factor for arterial occlusive diseases. Folic acid (FA) supplementation usually lowers tHcy levels, but initial tHcy and vitamin levels, multivitamin use, and polymo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49f7d4032a723822af496de35a1b769
https://doi.org/10.1161/01.atv.17.6.1157
https://doi.org/10.1161/01.atv.17.6.1157
Autor:
Glenn T Gerhard, Paul Barton Duell
Publikováno v:
Current opinion in lipidology. 10(5)
Elevated plasma total homocysteine is an independent risk factor for atherosclerotic vascular disease. Risk rises continuously across the spectrum of homocysteine concentrations and may become appreciable at levels greater than 10 mumol/l. A compelli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b042470598c6791285e9336621e79077
https://pubmed.ncbi.nlm.nih.gov/10554704
https://pubmed.ncbi.nlm.nih.gov/10554704